Literature DB >> 9344880

The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways.

C L Yu1, P Driggers, G Barrera-Hernandez, S B Nunez, J H Segars, S Cheng.   

Abstract

The estrogen receptor (ER) is a ligand-dependent transcription factor which regulates growth, development, differentiation and reproduction. To test the hypothesis that the diverse effects of the ER could be mediated by interacting with other transcription factors/oncogenes, the present study assessed its interaction with the tumor suppressor p53. p53 is a transcription factor which is involved in cell cycle regulation and apoptosis. We found that the wild-type p53 physically interacted with ER in vivo and repressed the estrogen-activated transcriptional activity. However, p53 mutants had no or reduced repression effect, depending on the sites of mutation. These findings suggest that p53 can cross talk with the ER in hormone-activated signaling pathways in cells. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344880     DOI: 10.1006/bbrc.1997.7522

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.

Authors:  Francesca De Amicis; Francesca Giordano; Adele Vivacqua; Michele Pellegrino; Maria Luisa Panno; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  FASEB J       Date:  2011-07-07       Impact factor: 5.191

2.  A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1.

Authors:  Daniel Menendez; Alberto Inga; Joyce Snipe; Oliver Krysiak; Gilbert Schönfelder; Michael A Resnick
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

3.  Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.

Authors:  Chad Deisenroth; Aaron R Thorner; Takeharu Enomoto; Charles M Perou; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 4.  Antiestrogens--tamoxifen, SERMs and beyond.

Authors:  K Dhingra
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.

Authors:  Crystal E Berger; Yingjuan Qian; Gang Liu; Hongwu Chen; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

6.  Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.

Authors:  Olga Fedorova; Alexey Petukhov; Alexandra Daks; Oleg Shuvalov; Tatyana Leonova; Elena Vasileva; Nikolai Aksenov; Gerry Melino; Nikolai A Barlev
Journal:  Oncogene       Date:  2018-11-19       Impact factor: 9.867

7.  Estrogen receptor prevents p53-dependent apoptosis in breast cancer.

Authors:  Shannon T Bailey; Hyunjin Shin; Thomas Westerling; Xiaole Shirley Liu; Myles Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-17       Impact factor: 11.205

8.  Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells.

Authors:  Stephanie Harkey Shirley; Joyce E Rundhaug; Jie Tian; Noirin Cullinan-Ammann; Isabel Lambertz; Claudio J Conti; Robin Fuchs-Young
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 9.  The p53-estrogen receptor loop in cancer.

Authors:  C Berger; Y Qian; X Chen
Journal:  Curr Mol Med       Date:  2013-09       Impact factor: 2.222

10.  LKB1 catalytic activity contributes to estrogen receptor alpha signaling.

Authors:  Suchita Nath-Sain; Paola A Marignani
Journal:  Mol Biol Cell       Date:  2009-04-15       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.